Details for New Drug Application (NDA): 019681

✉ Email this page to a colleague

NDA 019681 describes AMINOSYN II 5% IN DEXTROSE 25% IN PLASTIC CONTAINER, which is a drug marketed by Abbott, Hospira, and Hospira Inc, and is included in five NDAs. Additional details are available on the AMINOSYN II 5% IN DEXTROSE 25% IN PLASTIC CONTAINER profile page.

The generic ingredient in AMINOSYN II 5% IN DEXTROSE 25% IN PLASTIC CONTAINER is amino acids; calcium chloride; dextrose; magnesium chloride; potassium chloride; potassium phosphate, dibasic; sodium chloride. There are two drug master file entries for this compound. Additional details are available on the amino acids; calcium chloride; dextrose; magnesium chloride; potassium chloride; potassium phosphate, dibasic; sodium chloride profile page.

Tradename:	AMINOSYN II 5% IN DEXTROSE 25% IN PLASTIC CONTAINER
Applicant:	Hospira
Ingredient:	amino acids; dextrose
Patents:	0

Active Rx/OTC/Discontinued:	DISCN	Dosage:	INJECTABLE;INJECTION			Strength	3.5%;25GM/100ML
Approval Date:	Nov 1, 1988	TE:		RLD:	No

Active Rx/OTC/Discontinued:	DISCN	Dosage:	INJECTABLE;INJECTION			Strength	3.5%;5GM/100ML
Approval Date:	Nov 1, 1988	TE:		RLD:	No

Active Rx/OTC/Discontinued:	DISCN	Dosage:	INJECTABLE;INJECTION			Strength	4.25%;25GM/100ML
Approval Date:	Nov 1, 1988	TE:		RLD:	No

Complete Access Available with Subscription